Breaking News Instant updates and real-time market news.

ICPT

Intercept

$98.12

1.92 (2.00%)

11:29
09/21/17
09/21
11:29
09/21/17
11:29

Intercept sinks after FDA safety communication cites 19 patient deaths

The FDA, in its safety communication sent out today on Intercept Pharmaceuticals' Ocaliva, said it identified 19 cases of death, of which eight provided information about the cause. Intercept on September 12 told Bloomberg that 10 patients died while taking Ocaliva. In the 13 months after Ocaliva was approved in May 2016, the FDA says it received reports of serious liver injury or death associated with the drug. The cause of death was reported to be worsening of primary biliary cholangitis disease in seven cases, with cardiovascular disease cited in the other case. Seven of these eight cases described patients with moderate to severe decreased liver function who received Ocaliva 5 mg daily, instead of a dose no greater than 10 mg twice weekly as recommended in the label prescribing information for patients with this extent of decreased liver function, the agency said in its communication. Shares of Intercept are down 7%, or $6.72, to $91.40 in late morning trading.

ICPT Intercept
$98.12

1.92 (2.00%)

09/14/17
OPCO
09/14/17
NO CHANGE
Target $15
OPCO
Outperform
Intercept Ocaliva dynamics highlight PBC opportunity, says Oppenheimer
Oppenheimer analyst Jay Olson says the Dear Doctor letter for Intercept's (ICPT) Ocaliva raises awareness of unmet medical need for patients with primary biliary cholangitis, or PBC. Since patients with Child-Pugh B/C cirrhosis were not studied in Ocaliva trials, the analyst believes the FDA's collaboration with Intercept to leverage PK modeling for dosing guidance which is included in the label and emphasized in the Dear Doctor letter highlights the importance of providing novel treatments to PBC patients. Olson expects these events to have a positive impact on the treatment of all PBC patients, and says CymaBay (CBAY) may benefit from these dynamics. He reiterates an Outperform rating and $15 price target on CymaBay's shares.
09/20/17
JEFF
09/20/17
NO CHANGE
Target $275
JEFF
Buy
Intercept recent pullback a buying opportunity, says Jefferies
After hosting investor meetings with management, Jefferies analyst Michael Yee says the recent pullback in shares of Intercept Pharmaceuticals creates a buying opportunity. The analyst left the meetings more confident that the Street's reaction to the patient safety letter "was overblown and likely to subside." The stock is near a "floor valuation" of $80-$100 and gives no credit to nonalcoholic steatohepatitis in 2019, Yee tells investors in a research note. He keeps a Buy rating on Intercept with a $275 price target.
09/19/17
SBSH
09/19/17
NO CHANGE
Target $150
SBSH
Buy
Concern over Intercept 'Dear Doctor' letter overblown, says Citi
After finding 10 other drugs that have been the subject of a "Dear Doctor" letter related to liver toxicity issues, Citi analyst Joel Beatty believes concern over Intercept Pharmaceuticals' patient safety letter on Ocaliva is overblown. The risk that Ocaliva will be withdrawn from the market is "very low," and the risk that the drug will get a black box warning isn't as much of a given as it first appear, Beatty tells investors in a research note. Further, he believes the drug can still be commercially successful even with a black box warning. The analyst keeps a Buy rating on Intercept with a $150 price target.
09/14/17
RBCM
09/14/17
INITIATION
Target $244
RBCM
Outperform
Intercept initiated with an Outperform at RBC Capital
RBC Capital analyst Brian Abrahams started Intercept Pharmaceuticals with an Outperform rating and $244 price target. After speaking to physicians, the analyst believes Ocaliva's prospects in cholestatic disease are underappreciated and the drug's long-term potential in nonalcoholic Steatohepatitis "could be substantial." He views the stock as "meaningfully undervalued."

TODAY'S FREE FLY STORIES

QCOM

Qualcomm

$63.40

-0.59 (-0.92%)

, AVGO

Broadcom

$248.62

-1 (-0.40%)

13:36
02/22/18
02/22
13:36
02/22/18
13:36
Hot Stocks
Qualcomm announces letter sent to stockholders, video posted to site »

Qualcomm (QCOM) announced…

QCOM

Qualcomm

$63.40

-0.59 (-0.92%)

AVGO

Broadcom

$248.62

-1 (-0.40%)

NXPI

NXP Semiconductors

$125.60

0.04 (0.03%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

  • 06

    Mar

  • 22

    Mar

  • 23

    Mar

  • 27

    Mar

  • 28

    Mar

AUDVF

Audi AG

, VLKAY

Volkswagen

$40.43

-0.57 (-1.39%)

13:35
02/22/18
02/22
13:35
02/22/18
13:35
Periodicals
German prosecutors raid homes of former Audi board members, AFP says »

German prosecutors said…

AUDVF

Audi AG

VLKAY

Volkswagen

$40.43

-0.57 (-1.39%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ABX

Barrick Gold

$12.57

-0.0933 (-0.74%)

13:25
02/22/18
02/22
13:25
02/22/18
13:25
Conference/Events
Barrick Gold to host investor day »

Investor meeting to be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 25

    Feb

13:25
02/22/18
02/22
13:25
02/22/18
13:25
Conference/Events
Morgan Stanley insurance analysts to hold an analyst/industry conference call »

Analysts host Charles…

13:20
02/22/18
02/22
13:20
02/22/18
13:20
General news
Treasury's $29 B 7-year sale was a disappointment »

Treasury's $29 B…

CSGP

CoStar Group

$352.11

0.27 (0.08%)

13:18
02/22/18
02/22
13:18
02/22/18
13:18
Recommendations
CoStar Group analyst commentary  »

Stephens would be buyers…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 26

    Feb

  • 23

    May

$NSD

NASDAQ Market Internals

13:17
02/22/18
02/22
13:17
02/22/18
13:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

13:16
02/22/18
02/22
13:16
02/22/18
13:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

13:15
02/22/18
02/22
13:15
02/22/18
13:15
General news
Treasury Action: yields kicked up from lows »

Treasury Action: yields…

ALKS

Alkermes

$63.19

-1.56 (-2.41%)

, NKTR

Nektar

$86.45

3 (3.60%)

13:11
02/22/18
02/22
13:11
02/22/18
13:11
Hot Stocks
Analyst cuts Alkermes rating as cancer drug seems less effective than competitor »

Shares of Alkermes (ALKS)…

ALKS

Alkermes

$63.19

-1.56 (-2.41%)

NKTR

Nektar

$86.45

3 (3.60%)

BMY

Bristol-Myers

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 26

    Feb

  • 05

    Mar

  • 08

    Mar

  • 04

    Apr

  • 03

    May

CIDM

Cinedigm

$1.25

0.0201 (1.63%)

13:10
02/22/18
02/22
13:10
02/22/18
13:10
Hot Stocks
Cinedigm acquires North American rights to 'Class Rank' »

Cinedigm Corp has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Mar

FB

Facebook

$177.91

1.9 (1.08%)

13:09
02/22/18
02/22
13:09
02/22/18
13:09
Technical Analysis
Technical Take: Facebook trades near session lows »

The stock was last at…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

  • 26

    Feb

  • 28

    Feb

  • 07

    Mar

  • 18

    Mar

HPQ

HP Inc.

$21.52

0.345 (1.63%)

, LNVGY

Lenovo

$10.15

-0.01 (-0.10%)

13:09
02/22/18
02/22
13:09
02/22/18
13:09
Earnings
On The Fly: What to watch for in HP Inc.'s earnings report »

HP Inc. (HPQ) is…

HPQ

HP Inc.

$21.52

0.345 (1.63%)

LNVGY

Lenovo

$10.15

-0.01 (-0.10%)

AAPL

Apple

$171.07

-0.78 (-0.45%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 23

    Feb

  • 26

    Feb

  • 24

    Apr

  • 30

    May

MIC

Macquarie Infrastructure

$39.09

-24.53 (-38.56%)

13:09
02/22/18
02/22
13:09
02/22/18
13:09
Recommendations
Macquarie Infrastructure analyst commentary  »

Macquarie Infrastructure…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

BAMXY

BMW Group

13:05
02/22/18
02/22
13:05
02/22/18
13:05
Hot Stocks
BMW to pay $2.2M to settle DOJ claims of SCRA violations »

The Justice Department…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

13:05
02/22/18
02/22
13:05
02/22/18
13:05
General news
7-Yr Note Auction Coupon Rate data reported »

7-Yr Note Auction Coupon…

13:05
02/22/18
02/22
13:05
02/22/18
13:05
General news
7-Yr Note Auction Total Amount data reported »

7-Yr Note Auction Total…

W

Wayfair

$74.55

-21.14 (-22.09%)

13:05
02/22/18
02/22
13:05
02/22/18
13:05
Recommendations
Wayfair analyst commentary  »

Citi trims Wayfair target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

EAT

Brinker

13:05
02/22/18
02/22
13:05
02/22/18
13:05
Options
Brinker call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VIAB

Viacom

$33.03

-0.95 (-2.80%)

, VIA

Viacom

$38.35

-1.15 (-2.91%)

13:04
02/22/18
02/22
13:04
02/22/18
13:04
Hot Stocks
SEGA, Paramount announce agreement to co-produce Sonic the Hedgehog feature film »

SEGA Holdings announced…

VIAB

Viacom

$33.03

-0.95 (-2.80%)

VIA

Viacom

$38.35

-1.15 (-2.91%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

  • 26

    Feb

GOOGL

Alphabet Class A

$1,113.75

10.16 (0.92%)

12:55
02/22/18
02/22
12:55
02/22/18
12:55
Technical Analysis
Technical Take: Alphabet Class A moves lower in intraday rounding pattern »

The shares have dropped…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

DPS

Dr Pepper Snapple

$115.28

-0.1 (-0.09%)

12:55
02/22/18
02/22
12:55
02/22/18
12:55
Options
Dr Pepper Snapple put volume heavy and directionally bearish »

Bearish flow noted in Dr…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

12:55
02/22/18
02/22
12:55
02/22/18
12:55
General news
Treasury Option Action: a rash of put buying »

Treasury Option Action: a…

12:55
02/22/18
02/22
12:55
02/22/18
12:55
Conference/Events
CFA Society of Milwaukee to hold a luncheon discussion »

Bill Stone, CMT of PNC…

12:55
02/22/18
02/22
12:55
02/22/18
12:55
Conference/Events
STAT Plus to hold webinar »

STAT Senior Science…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.